Select for export Special considerations for evaluating psilocybin-facilitated psychotherapy in vulnerable populations. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuropharm.2022.109127 PubMed 35577136 Copy citation Copy BibTeX Unknown journal 2022-05-12 Ortiz CE, Dourron HM, Sweat NW, Garcia-Romeu A, MacCarthy S, Anderson BT Europe PMC Published psilocybin General Other More
Select for export Receptor binding profiles and behavioral effects of psilocybin analogs Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1096/fasebj.2022.36.s1.r3639 Copy citation Copy BibTeX The FASEB Journal 2022-04-30 Grant C. Glatfelter, David R. Manke, Andrew R. Chadayne, Michael H. Baumann OpenAlex Published psilocybinpsilocin PharmacologyReceptor PharmacologyAnimal Study Animal Study More
Select for export Socio-psychedelic imaginaries: envisioning and building legal psychedelic worlds in the United States Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40309-022-00199-2 Copy citation Copy BibTeX European Journal of Futures Research 2022-04-29 Claudia Schwarz-Plaschg OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/14740338.2022.2066650 PubMed 35426754 Copy citation Copy BibTeX Expert Opinion on Drug Safety 2022-04-26 Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG. Europe PMC Published psilocybin DepressionMechanism of ActionClinical Trial Randomized Controlled Trial More
Select for export Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pharmthera.2022.108195 PubMed 35489438 Copy citation Copy BibTeX Unknown journal 2022-04-26 Raut SB, Marathe PA, van Eijk L, Eri R, Ravindran M, Benedek DM Europe PMC Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.psychres.2022.114577 PubMed 35580433 Copy citation Copy BibTeX Unknown journal 2022-04-25 Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB Europe PMC Published psilocybin DepressionBrain ImagingAging Clinical Trial More
Select for export Serotonergic psychedelic drugs LSD and psilocybin reduce the hierarchical differentiation of unimodal and transmodal cortex. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.neuroimage.2022.119220 PubMed 35483649 Copy citation Copy BibTeX NeuroImage 2022-04-24 Girn M, Roseman L, Bernhardt B, Smallwood J, Carhart-Harris R, Nathan Spreng R. Europe PMC Published psilocybin Brain ImagingReceptor PharmacologyAging Other More
Select for export Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/molecules27082520 PubMed 35458717 Copy citation Copy BibTeX Unknown journal 2022-04-13 Lowe H, Toyang N, Steele B, Grant J, Ali A, Gordon L Europe PMC Published psilocybin DepressionAnxietyAddiction Review Article More
Select for export Increased global integration in the brain after psilocybin therapy for depression. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41591-022-01744-z PubMed 35411074 Copy citation Copy BibTeX Nature Medicine 2022-04-10 Daws RE, Timmermann C, Giribaldi B, Sexton JD, Wall MB, Erritzoe D Europe PMC Published psilocybin DepressionBrain ImagingReceptor Pharmacology Randomized Controlled Trial More
Select for export Associations between classic psychedelics and opioid use disorder in a nationally-representative U.S. adult sample. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-022-08085-4 PubMed 35393455 Copy citation Copy BibTeX Scientific Reports 2022-04-06 Jones G, Ricard JA, Lipson J, Nock MK. Europe PMC Published psilocybin AddictionClinical TrialObservational Study Clinical Trial More
Select for export Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811221084063 PubMed 35388724 Copy citation Copy BibTeX Journal of Psychopharmacology 2022-04-06 Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ. Europe PMC Published psilocybin AnxietySpiritualityObservational Study Observational Study More
Select for export Psilocybin increases brain network integration in patients with depression. No abstract availability was recorded for this entry. Details DOI 10.1038/s41591-022-01769-4 PubMed 35411079 Copy citation Copy BibTeX Nature Medicine 2022-03-31 Authors unavailable Europe PMC Published psilocybin Depression Other More
Select for export Models of psychedelic drug action: modulation of cortical-subcortical circuits. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/brain/awab406 PubMed 34897383 Copy citation Copy BibTeX Brain 2022-03-31 Doss MK, Madden MB, Gaddis A, Nebel MB, Griffiths RR, Mathur BN Europe PMC Published psilocybin Receptor Pharmacology Other More
Select for export Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/ijnp/pyab085 PubMed 34871422 Copy citation Copy BibTeX The International Journal of Neuropsychopharmacology 2022-03-31 Hackl B, Todt H, Kubista H, Hilber K, Koenig X. Europe PMC Published psilocybinpsilocin AgingClinical TrialSafety Clinical Trial More
Select for export Tentative identification of in vitro metabolites of O-acetylpsilocin (psilacetin, 4-AcO-DMT) by UHPLC-Q-Orbitrap MS. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1002/dta.3255 PubMed 35312166 Copy citation Copy BibTeX Drug Testing and Analysis 2022-03-28 Zhai W, Li L, Zhao J, Xiang P, Liu M, Shi Y Europe PMC Published psilocybinpsilocin PharmacologyBiomarkersEpigenetics Clinical Trial More
Select for export Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1176/appi.pn.2022.04.4.35 Copy citation Copy BibTeX Psychiatric News 2022-03-23 Michael Avissar, Adrian Jacques H. Ambrose OpenAlex Published psilocybin DepressionAnxietyPTSD Clinical Trial More
Select for export How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1080/02791072.2022.2047842 PubMed 35318904 Copy citation Copy BibTeX Journal of Psychoactive Drugs 2022-03-22 Earleywine M, Low F, Altman BR, De Leo J. Europe PMC Published psilocybin Depression Other More
Select for export The promises and perils of psychedelic pharmacology for psychiatry. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41573-022-00421-7 PubMed 35301459 Copy citation Copy BibTeX Unknown journal 2022-03-16 McClure-Begley TD, Roth BL. Europe PMC Published psilocybin DepressionAnxietyPharmacology Clinical Trial More
Select for export Phenomenological assessment of psychedelics induced experiences: Translation and validation of the German Challenging Experience Questionnaire (CEQ) and Ego-Dissolution Inventory (EDI). Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1371/journal.pone.0264927 PubMed 35294453 Copy citation Copy BibTeX PLoS ONE 2022-03-15 Dworatzyk K, Jansen T, Schmidt TT. Europe PMC Published psilocybin AnxietyConsciousnessMystical Experience Observational Study More
Select for export A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00048674221083868 PubMed 35285280 Copy citation Copy BibTeX Unknown journal 2022-03-11 Kisely S, Connor M, Somogyi AA, Siskind D. Europe PMC Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
